Skip to main content
Top
Published in: BMC Public Health 1/2009

Open Access 01-12-2009 | Research article

A case-control study of sporadic Creutzfeldt-Jakob disease in Switzerland: analysis of potential risk factors with regard to an increased CJD incidence in the years 2001–2004

Authors: Jessica Ruegger, Katharina Stoeck, Lorenz Amsler, Thomas Blaettler, Marcel Zwahlen, Adriano Aguzzi, Markus Glatzel, Klaus Hess, Tobias Eckert

Published in: BMC Public Health | Issue 1/2009

Login to get access

Abstract

Background

In 2001, the observed annual mortality from Creutzfeldt-Jakob disease (CJD) in Switzerland increased from less than 1.5 to 2.6 per million inhabitants. An underlying cause could not be identified.

Methods

To analyse potential risk factors for sCJD in Switzerland, close relatives of 69 sCJD-patients and 224 frequency age-matched controls were interviewed in a case-control study using a standardised questionnaire. 135 potential risk factors including socio-demographics, medical history, occupation and diet were analysed by logistic regression adjusting for age, sex and education.

Results

sCJD patients were more likely to have travelled abroad, worked at an animal laboratory, undergone invasive dental treatment, orthopaedic surgery, ophthalmologic surgery after 1980, regular GP visits, taken medication regularly, and consumed kidney. No differences between patients and controls were found for residency, family history, and exposure to environmental and other dietary factors.

Conclusion

Although some factors were significantly more frequent among sCJD-cases, this study did not reveal specific explanations for the increased incidence of deaths due to sporadic CJD observed in Switzerland since 2001. Results have to be interpreted with caution due to multiple testing and possible recall bias in association with a long incubation period. The most plausible reason for the increase in Swiss sCJD cases after 2000 is an improved case ascertainment. Therefore, underreporting of cases might well have occurred before the year 2001, and the "real" yearly incidence of sCJD might not be lower than, but rather above 2 per million inhabitants.
Appendix
Available only for authorised users
Literature
1.
go back to reference Prusiner SB: Novel proteinaceous infectious particles cause scrapie. Science. 1982, 216 (4542): 136-44. 10.1126/science.6801762.CrossRefPubMed Prusiner SB: Novel proteinaceous infectious particles cause scrapie. Science. 1982, 216 (4542): 136-44. 10.1126/science.6801762.CrossRefPubMed
2.
go back to reference Poser S, Zerr I, Schulz-Schaeffer WJ, Kretzschmar HA, Felgenhauer K: Dtsch med Wochenschr. 1997, 122 (37): 1099-105. 10.1055/s-2008-1047733.CrossRefPubMed Poser S, Zerr I, Schulz-Schaeffer WJ, Kretzschmar HA, Felgenhauer K: Dtsch med Wochenschr. 1997, 122 (37): 1099-105. 10.1055/s-2008-1047733.CrossRefPubMed
3.
go back to reference Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, Poser S, Pocchiari M, Hofman A, Smith PG: A new variant of Creutzfeldt-Jakob disease in the UK. Lancet. 1996, 347 (9006): 921-925. 10.1016/S0140-6736(96)91412-9.CrossRefPubMed Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, Poser S, Pocchiari M, Hofman A, Smith PG: A new variant of Creutzfeldt-Jakob disease in the UK. Lancet. 1996, 347 (9006): 921-925. 10.1016/S0140-6736(96)91412-9.CrossRefPubMed
4.
go back to reference Collinge J, Sidle KC, Meads J, Ironside J, Hill AF: Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature. 1996, 383 (6602): 685-90. 10.1038/383685a0.CrossRefPubMed Collinge J, Sidle KC, Meads J, Ironside J, Hill AF: Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature. 1996, 383 (6602): 685-90. 10.1038/383685a0.CrossRefPubMed
5.
go back to reference Masters CL, Harris JO, Gajdusek DC, Gibbs CJ, Bernoulli C, Asher DM: Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol. 1979, 5 (2): 177-88. 10.1002/ana.410050212.CrossRefPubMed Masters CL, Harris JO, Gajdusek DC, Gibbs CJ, Bernoulli C, Asher DM: Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol. 1979, 5 (2): 177-88. 10.1002/ana.410050212.CrossRefPubMed
6.
go back to reference Centers for Disease Control, Atlanta, USA: Rapidly progressive dementia in a patient who received a cadaveric dura mater graft. MMWR Morb Mortal Wkly Rep. 1987, 36 (4): 49-50. Centers for Disease Control, Atlanta, USA: Rapidly progressive dementia in a patient who received a cadaveric dura mater graft. MMWR Morb Mortal Wkly Rep. 1987, 36 (4): 49-50.
7.
go back to reference Centers for Disease Control, Atlanta, USA: Update: Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts – Japan, 1979–2003. MMWR Morb Mortal Wkly Rep. 2003, 52 (48): 1179-81. Centers for Disease Control, Atlanta, USA: Update: Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts – Japan, 1979–2003. MMWR Morb Mortal Wkly Rep. 2003, 52 (48): 1179-81.
8.
go back to reference Brown PPM, Brandel JP, Sato T, McShane L, Zerr I, Fletcher A, Will RG, Pocchiari M, Cashman NR, d'Aignaux JH, Cervenakova L, Fradkin J, Schonberger LB, Collins SJ: Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology. 2000, 55 (8): 1075-81.CrossRefPubMed Brown PPM, Brandel JP, Sato T, McShane L, Zerr I, Fletcher A, Will RG, Pocchiari M, Cashman NR, d'Aignaux JH, Cervenakova L, Fradkin J, Schonberger LB, Collins SJ: Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology. 2000, 55 (8): 1075-81.CrossRefPubMed
9.
go back to reference Brown P, Preece MA, Will RG: "Friendly fire" in medicine: hormones, homografts, and Creutzfeldt-Jakob disease. Lancet. 1992, 340 (8810): 24-7. 10.1016/0140-6736(92)92431-E.CrossRefPubMed Brown P, Preece MA, Will RG: "Friendly fire" in medicine: hormones, homografts, and Creutzfeldt-Jakob disease. Lancet. 1992, 340 (8810): 24-7. 10.1016/0140-6736(92)92431-E.CrossRefPubMed
10.
go back to reference Blattler T: Implications of prion diseases for neurosurgery. Neurosurg Rev. 2002, 25 (4): 195-203. 10.1007/s101430100170.CrossRefPubMed Blattler T: Implications of prion diseases for neurosurgery. Neurosurg Rev. 2002, 25 (4): 195-203. 10.1007/s101430100170.CrossRefPubMed
11.
go back to reference Aguzzi A, Glatzel M: Prion infections, blood and transfusions. Nat Clin Pract Neurol. 2006, 2 (6): 321-9. 10.1038/ncpneuro0214.CrossRefPubMed Aguzzi A, Glatzel M: Prion infections, blood and transfusions. Nat Clin Pract Neurol. 2006, 2 (6): 321-9. 10.1038/ncpneuro0214.CrossRefPubMed
12.
go back to reference Brown P, Brandel JP, Preece M, Sato T: Iatrogenic Creutzfeldt-Jakob disease: the waning of an era. Neurology. 2006, 67 (3): 389-93. 10.1212/01.wnl.0000231528.65069.3f.CrossRefPubMed Brown P, Brandel JP, Preece M, Sato T: Iatrogenic Creutzfeldt-Jakob disease: the waning of an era. Neurology. 2006, 67 (3): 389-93. 10.1212/01.wnl.0000231528.65069.3f.CrossRefPubMed
13.
go back to reference de Pedro-Cuesta J, Glatzel M, Almazan J, Stoeck K, Mellina V, Puopolo M, Pocchiari M, Zerr I, Kretszchmar HA, Brandel JP, Delasnerie-Laupretre N, Alperovitch A, Van Duijn C, Sanchez-Juan P, Collins S, Lewis V, Jansen GH, Coulthart MB, Gelpi E, Budka H, Mitrova E: Human transmissible spongiform encephalopathies in eleven countries: diagnostic pattern across time, 1993–2002. BMC Public Health. 2006, 6: 278-10.1186/1471-2458-6-278.CrossRefPubMedPubMedCentral de Pedro-Cuesta J, Glatzel M, Almazan J, Stoeck K, Mellina V, Puopolo M, Pocchiari M, Zerr I, Kretszchmar HA, Brandel JP, Delasnerie-Laupretre N, Alperovitch A, Van Duijn C, Sanchez-Juan P, Collins S, Lewis V, Jansen GH, Coulthart MB, Gelpi E, Budka H, Mitrova E: Human transmissible spongiform encephalopathies in eleven countries: diagnostic pattern across time, 1993–2002. BMC Public Health. 2006, 6: 278-10.1186/1471-2458-6-278.CrossRefPubMedPubMedCentral
14.
go back to reference Hillier CE, Salmon RL: Is there evidence for exogenous risk factors in the aetiology and spread of Creutzfeldt-Jakob disease?. Qjm. 2000, 93 (9): 617-31. 10.1093/qjmed/93.9.617.CrossRefPubMed Hillier CE, Salmon RL: Is there evidence for exogenous risk factors in the aetiology and spread of Creutzfeldt-Jakob disease?. Qjm. 2000, 93 (9): 617-31. 10.1093/qjmed/93.9.617.CrossRefPubMed
15.
go back to reference Glatzel M, Rogivue C, Ghani A, Streffer JR, Amsler L, Aguzzi A: Incidence of Creutzfeldt-Jakob disease in Switzerland. Lancet. 2002, 360 (9327): 139-41. 10.1016/S0140-6736(02)09384-4.CrossRefPubMed Glatzel M, Rogivue C, Ghani A, Streffer JR, Amsler L, Aguzzi A: Incidence of Creutzfeldt-Jakob disease in Switzerland. Lancet. 2002, 360 (9327): 139-41. 10.1016/S0140-6736(02)09384-4.CrossRefPubMed
18.
go back to reference Cohen CH: Does improvement in case ascertainment explain the increase in sporadic Creutzfeldt-Jakob disease since 1970 in the United Kingdom?. Am J Epidemiol. 2000, 152 (5): 474-9. 10.1093/aje/152.5.474.CrossRefPubMed Cohen CH: Does improvement in case ascertainment explain the increase in sporadic Creutzfeldt-Jakob disease since 1970 in the United Kingdom?. Am J Epidemiol. 2000, 152 (5): 474-9. 10.1093/aje/152.5.474.CrossRefPubMed
19.
go back to reference Horan G, Keohane C, Molloy S, Howley R, Harney M, Heffernan J, McGuigan C, Hutchinson M, Brett F, Farrell M: Creutzfeldt-Jakob disease in Ireland: epidemiological aspects 1980–2002. Eur Neurol. 2004, 51 (3): 132-7. 10.1159/000077063.CrossRefPubMed Horan G, Keohane C, Molloy S, Howley R, Harney M, Heffernan J, McGuigan C, Hutchinson M, Brett F, Farrell M: Creutzfeldt-Jakob disease in Ireland: epidemiological aspects 1980–2002. Eur Neurol. 2004, 51 (3): 132-7. 10.1159/000077063.CrossRefPubMed
20.
go back to reference Llewelyn CA, Hewitt PE, Knight RS, Amar K, Cousens S, Mackenzie J, Will RG: Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet. 2004, 363 (9407): 417-21. 10.1016/S0140-6736(04)15486-X.CrossRefPubMed Llewelyn CA, Hewitt PE, Knight RS, Amar K, Cousens S, Mackenzie J, Will RG: Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet. 2004, 363 (9407): 417-21. 10.1016/S0140-6736(04)15486-X.CrossRefPubMed
21.
go back to reference Schaller P, Schwermer H, Heim D: [Twelve years experience in Switzerland: Quo vadis BSE?]. [Article in German] Schweiz Arch Tierheilkd. 2002, 144 (12): 716-27. 10.1024/0036-7281.144.12.716.CrossRefPubMed Schaller P, Schwermer H, Heim D: [Twelve years experience in Switzerland: Quo vadis BSE?]. [Article in German] Schweiz Arch Tierheilkd. 2002, 144 (12): 716-27. 10.1024/0036-7281.144.12.716.CrossRefPubMed
22.
go back to reference Stoeck K, Hess K, Amsler L, Eckert T, Zimmermann D, Aguzzi A, Glatzel M: Heightened incidence of sporadic Creutzfeldt-Jakob disease is associated with a shift in clinicopathological profiles. J Neurol. 2008, 255 (10): 1464-72. 10.1007/s00415-008-0900-0.CrossRefPubMed Stoeck K, Hess K, Amsler L, Eckert T, Zimmermann D, Aguzzi A, Glatzel M: Heightened incidence of sporadic Creutzfeldt-Jakob disease is associated with a shift in clinicopathological profiles. J Neurol. 2008, 255 (10): 1464-72. 10.1007/s00415-008-0900-0.CrossRefPubMed
23.
go back to reference Ward HJ, Everington D, Croes EA, Alperovitch A, Delasnerie-Laupretre N, Zerr I, Poser S, van Duijn CM: Sporadic Creutzfeldt-Jakob disease and surgery: a case-control study using community controls. Neurology. 2002, 59 (4): 543-8.CrossRefPubMed Ward HJ, Everington D, Croes EA, Alperovitch A, Delasnerie-Laupretre N, Zerr I, Poser S, van Duijn CM: Sporadic Creutzfeldt-Jakob disease and surgery: a case-control study using community controls. Neurology. 2002, 59 (4): 543-8.CrossRefPubMed
24.
go back to reference Everington D, Smith AJ, Ward HJ, Letters S, Will RG, Bagg J: Dental treatment and risk of variant CJD – a case control study. Br Dent J. 2007, 202 (8): E19-10.1038/bdj.2007.126.CrossRefPubMed Everington D, Smith AJ, Ward HJ, Letters S, Will RG, Bagg J: Dental treatment and risk of variant CJD – a case control study. Br Dent J. 2007, 202 (8): E19-10.1038/bdj.2007.126.CrossRefPubMed
25.
go back to reference StataCorp: Stata Statistical Software: Release 8.0. 2003, College Station, TX: Stata Corporation StataCorp: Stata Statistical Software: Release 8.0. 2003, College Station, TX: Stata Corporation
26.
go back to reference Davanipour Z, Alter M, Sobel E, Asher DM, Gajdusek DC: A case-control study of Creutzfeldt-Jakob disease. Dietary risk factors. Am J Epidemiol. 1985, 122 (3): 443-51.PubMed Davanipour Z, Alter M, Sobel E, Asher DM, Gajdusek DC: A case-control study of Creutzfeldt-Jakob disease. Dietary risk factors. Am J Epidemiol. 1985, 122 (3): 443-51.PubMed
27.
go back to reference van Duijn CM, Delasnerie-Laupretre N, Masullo C, Zerr I, de Silva R, Wientjens DP, Brandel JP, Weber T, Bonavita V, Zeidler M, Alperovitch A, Poser S, Granieri E, Hofman A, Will RG: Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993–95. European Union (EU) Collaborative Study Group of Creutzfeldt-Jakob disease (CJD). Lancet. 1998, 351 (9109): 1081-5. 10.1016/S0140-6736(97)09468-3.CrossRefPubMed van Duijn CM, Delasnerie-Laupretre N, Masullo C, Zerr I, de Silva R, Wientjens DP, Brandel JP, Weber T, Bonavita V, Zeidler M, Alperovitch A, Poser S, Granieri E, Hofman A, Will RG: Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993–95. European Union (EU) Collaborative Study Group of Creutzfeldt-Jakob disease (CJD). Lancet. 1998, 351 (9109): 1081-5. 10.1016/S0140-6736(97)09468-3.CrossRefPubMed
28.
go back to reference Kondo K, Kuroiwa Y: A case control study of Creutzfeldt-Jakob disease: association with physical injuries. Ann Neurol. 1982, 11 (4): 377-81. 10.1002/ana.410110410.CrossRefPubMed Kondo K, Kuroiwa Y: A case control study of Creutzfeldt-Jakob disease: association with physical injuries. Ann Neurol. 1982, 11 (4): 377-81. 10.1002/ana.410110410.CrossRefPubMed
29.
go back to reference Wientjens DP, Davanipour Z, Hofman A, Kondo K, Matthews WB, Will RG, van Duijn CM: Risk factors for Creutzfeldt-Jakob disease: a reanalysis of case-control studies. Neurology. 1996, 46 (5): 1287-91.CrossRefPubMed Wientjens DP, Davanipour Z, Hofman A, Kondo K, Matthews WB, Will RG, van Duijn CM: Risk factors for Creutzfeldt-Jakob disease: a reanalysis of case-control studies. Neurology. 1996, 46 (5): 1287-91.CrossRefPubMed
30.
go back to reference Harries-Jones R, Knight R, Will RG, Cousens S, Smith PG, Matthews WB: Creutzfeldt-Jakob disease in England and Wales, 1980–1984: a case-control study of potential risk factors. J Neurol Neurosurg Psychiatry. 1988, 51 (9): 1113-9. 10.1136/jnnp.51.9.1113.CrossRefPubMedPubMedCentral Harries-Jones R, Knight R, Will RG, Cousens S, Smith PG, Matthews WB: Creutzfeldt-Jakob disease in England and Wales, 1980–1984: a case-control study of potential risk factors. J Neurol Neurosurg Psychiatry. 1988, 51 (9): 1113-9. 10.1136/jnnp.51.9.1113.CrossRefPubMedPubMedCentral
31.
go back to reference Collins S, Law MG, Fletcher A, Boyd A, Kaldor J, Masters CL: Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study. Lancet. 1999, 353 (9154): 693-7. 10.1016/S0140-6736(98)08138-0.CrossRefPubMed Collins S, Law MG, Fletcher A, Boyd A, Kaldor J, Masters CL: Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study. Lancet. 1999, 353 (9154): 693-7. 10.1016/S0140-6736(98)08138-0.CrossRefPubMed
32.
go back to reference Cocco PL, Caperna A, Vinci F: Occupational risk factors for the sporadic form of Creutzfeldt-Jakob disease. Med Lav. 2003, 94 (4): 353-63.PubMed Cocco PL, Caperna A, Vinci F: Occupational risk factors for the sporadic form of Creutzfeldt-Jakob disease. Med Lav. 2003, 94 (4): 353-63.PubMed
33.
go back to reference Stern Y, Gurland B, Tatemichi TK, Tang MX, Wilder D, Mayeux R: Influence of education and occupation on the incidence of Alzheimer's disease. JAMA. 1994, 271 (13): 1004-10. 10.1001/jama.271.13.1004.CrossRefPubMed Stern Y, Gurland B, Tatemichi TK, Tang MX, Wilder D, Mayeux R: Influence of education and occupation on the incidence of Alzheimer's disease. JAMA. 1994, 271 (13): 1004-10. 10.1001/jama.271.13.1004.CrossRefPubMed
34.
go back to reference Laske C, Gefeller O, Pfahlberg A, Zerr I, Schroter A, Poser S: The effect of stress on the onset and progression of Creutzfeldt-Jakob disease: results of a German pilot case-control study. Eur J Epidemiol. 1999, 15 (7): 631-5. 10.1023/A:1007683208121.CrossRefPubMed Laske C, Gefeller O, Pfahlberg A, Zerr I, Schroter A, Poser S: The effect of stress on the onset and progression of Creutzfeldt-Jakob disease: results of a German pilot case-control study. Eur J Epidemiol. 1999, 15 (7): 631-5. 10.1023/A:1007683208121.CrossRefPubMed
35.
go back to reference Davanipour Z, Alter M, Sobel E, Asher D, Gajdusek DC: Creutzfeldt-Jakob disease: possible medical risk factors. Neurology. 1985, 35 (10): 1483-6.CrossRefPubMed Davanipour Z, Alter M, Sobel E, Asher D, Gajdusek DC: Creutzfeldt-Jakob disease: possible medical risk factors. Neurology. 1985, 35 (10): 1483-6.CrossRefPubMed
36.
go back to reference Zerr I, Brandel JP, Masullo C, Wientjens D, de Silva R, Zeidler M, Granieri E, Sampaolo S, van Duijn C, Delasnerie-Laupretre N, Will R, Poser S: European surveillance on Creutzfeldt-Jakob disease: a case-control study for medical risk factors. J Clin Epidemiol. 2000, 53 (7): 747-54. 10.1016/S0895-4356(99)00207-3.CrossRefPubMed Zerr I, Brandel JP, Masullo C, Wientjens D, de Silva R, Zeidler M, Granieri E, Sampaolo S, van Duijn C, Delasnerie-Laupretre N, Will R, Poser S: European surveillance on Creutzfeldt-Jakob disease: a case-control study for medical risk factors. J Clin Epidemiol. 2000, 53 (7): 747-54. 10.1016/S0895-4356(99)00207-3.CrossRefPubMed
37.
go back to reference Glatzel M, Abela E, Maissen M, Aguzzi A: Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. N Engl J Med. 2003, 349 (19): 1812-20. 10.1056/NEJMoa030351.CrossRefPubMed Glatzel M, Abela E, Maissen M, Aguzzi A: Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. N Engl J Med. 2003, 349 (19): 1812-20. 10.1056/NEJMoa030351.CrossRefPubMed
38.
go back to reference Esmonde TF, Will RG, Slattery JM, Knight R, Harries Jones R, de Silva R, Matthews WB: Creutzfeldt-Jakob disease and blood transfusion. Lancet. 1993, 341 (8839): 205-7. 10.1016/0140-6736(93)90068-R.CrossRefPubMed Esmonde TF, Will RG, Slattery JM, Knight R, Harries Jones R, de Silva R, Matthews WB: Creutzfeldt-Jakob disease and blood transfusion. Lancet. 1993, 341 (8839): 205-7. 10.1016/0140-6736(93)90068-R.CrossRefPubMed
39.
go back to reference Wilson K, Code C, Ricketts MN: Risk of acquiring Creutzfeldt-Jakob disease from blood transfusions: systematic review of case-control studies. BMJ. 2000, 321 (7252): 17-9. 10.1136/bmj.321.7252.17.CrossRefPubMedPubMedCentral Wilson K, Code C, Ricketts MN: Risk of acquiring Creutzfeldt-Jakob disease from blood transfusions: systematic review of case-control studies. BMJ. 2000, 321 (7252): 17-9. 10.1136/bmj.321.7252.17.CrossRefPubMedPubMedCentral
40.
go back to reference Vollmert C, Windl O, Xiang W, Rosenberger A, Zerr I, Wichmann HE, Bickeböller H, Illig T, KORA group, Kretzschmar HA: Significant association of a M129V independent polymorphism in the 5' UTR of the PRNP gene with sporadic Creutzfeldt-Jakob disease in a large German case-control study. J Med Genet. 2006, 43 (10): e53-10.1136/jmg.2006.040931.CrossRefPubMedPubMedCentral Vollmert C, Windl O, Xiang W, Rosenberger A, Zerr I, Wichmann HE, Bickeböller H, Illig T, KORA group, Kretzschmar HA: Significant association of a M129V independent polymorphism in the 5' UTR of the PRNP gene with sporadic Creutzfeldt-Jakob disease in a large German case-control study. J Med Genet. 2006, 43 (10): e53-10.1136/jmg.2006.040931.CrossRefPubMedPubMedCentral
41.
go back to reference Sánchez-Juan P, Bishop MT, Green A, Giannattasio C, Arias-Vasquez A, Poleggi A, Knight RS, van Duijn CM: No evidence for association between tau gene haplotypic variants and susceptibility to Creutzfeldt-Jakob disease. BMC Med Genet. 2007, 8: 77-10.1186/1471-2350-8-77.CrossRefPubMedPubMedCentral Sánchez-Juan P, Bishop MT, Green A, Giannattasio C, Arias-Vasquez A, Poleggi A, Knight RS, van Duijn CM: No evidence for association between tau gene haplotypic variants and susceptibility to Creutzfeldt-Jakob disease. BMC Med Genet. 2007, 8: 77-10.1186/1471-2350-8-77.CrossRefPubMedPubMedCentral
42.
go back to reference Ward HJ, Everington D, Cousens SN, Smith-Bathgate B, Gillies M, Murray K, Knight RS, Smith PG, Will RG: Risk factors for sporadic Creutzfeldt-Jakob disease. Ann Neurol. 2008, 63 (3): 347-54. 10.1002/ana.21294.CrossRefPubMed Ward HJ, Everington D, Cousens SN, Smith-Bathgate B, Gillies M, Murray K, Knight RS, Smith PG, Will RG: Risk factors for sporadic Creutzfeldt-Jakob disease. Ann Neurol. 2008, 63 (3): 347-54. 10.1002/ana.21294.CrossRefPubMed
43.
go back to reference Schoch G, Seeger H, Bogousslavsky J, Tolnay M, Janzer RC, et al: Analysis of prion strains by PrPSc profiling in sporadic Creutzfeldt-Jakob disease. PLoS Med. 2006, 3 (2): e14-10.1371/journal.pmed.0030014.CrossRefPubMed Schoch G, Seeger H, Bogousslavsky J, Tolnay M, Janzer RC, et al: Analysis of prion strains by PrPSc profiling in sporadic Creutzfeldt-Jakob disease. PLoS Med. 2006, 3 (2): e14-10.1371/journal.pmed.0030014.CrossRefPubMed
Metadata
Title
A case-control study of sporadic Creutzfeldt-Jakob disease in Switzerland: analysis of potential risk factors with regard to an increased CJD incidence in the years 2001–2004
Authors
Jessica Ruegger
Katharina Stoeck
Lorenz Amsler
Thomas Blaettler
Marcel Zwahlen
Adriano Aguzzi
Markus Glatzel
Klaus Hess
Tobias Eckert
Publication date
01-12-2009
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2009
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-9-18

Other articles of this Issue 1/2009

BMC Public Health 1/2009 Go to the issue